MAPS 2025 Americas Meeting: New Orleans
2025-03-23 00:00 - 2025-03-26 23:59 (America/Chicago)
Add to Calendar

Save the date!! Join us in New Orleans, Louisiana on March 23-26, 2025. More Information Coming Soon.

Impact in Action: Driving Health Equity Through Medical Affairs Excellence With Conscious Inclusion
2025-04-04 10:00 - 11:00 (America/New_York)
Health disparities pose a critical challenge, particularly for underrepresented populations. Medical Affairs is uniquely positioned to bridge the gap between scientific innovation and patient needs by leveraging expertise and real-world evidence to address systemic barriers driving health inequities.

This webinar explores the vital role of Medical Affairs and healthcare professionals in advancing health equity through consciously inclusive strategies. Topics include promoting equitable clinical trial access, enhancing diverse representation in research, and improving healthcare delivery systems. Evidence-based best practices will be shared, offering insights into increasing trial diversity, aligning organizational objectives with equity goals, and advocating for policy reforms that prioritize underserved populations.

Attendees will gain actionable insights, including case studies of successful initiatives, highlighting meaningful engagement with diverse communities. The session will emphasize how inclusive practices can strengthen stakeholder relationships, improve communication strategies, and enhance the impact of scientific and strategic outputs. These efforts aim to empower participants to address diverse patient needs, drive innovation, and create lasting organizational and societal value.

This webinar is essential for those committed to leveraging science to transform healthcare through equitable and inclusive approaches, ensuring better outcomes for all.

Learning Objectives:

Promote equitable clinical trial access and enhance diverse representation in research.

Align organizational objectives with health equity goals and advocate for policy reforms.

Implement inclusive practices to improve stakeholder relationships and communication strategies.

Register

Speaker:

Naseem Ahmed

Global Director, Diversity, Equity, and Inclusion

Inizio Medical

Speaker:

Matt Wadyka

President, US Medical Affairs

Inizio Medical

Speaker:

Laëtitia Bouérat Duvold

Senior Director, Head of Global Medical Affairs Excellence

Lundbeck

Speaker:

Ronaldo Enoch, MS

Director, Health of Diversity & Inclusion in Clinical Trials

Kite Pharma

A Holistic View of Medical Affairs: Exploring the Critical Dimensions, Roles, and Sub-functions
2025-04-10 16:30 - 19:00 (America/North_Dakota/Center)
Medical Affairs serves as the bridge between science, strategy, and clinical practice, playing an essential role in the success of pharmaceutical and medical device companies. This panel discussion will provide a holistic exploration of Medical Affairs, delving into its critical dimensions, diverse roles, and interconnected sub-functions. Experts will discuss how Medical Affairs teams drive innovation, foster cross-functional collaboration, and enhance patient outcomes by bridging gaps between R&D, marketing, and healthcare stakeholders.

Panel Objectives

Define Key Functions: Explore the core responsibilities and sub-functions of Medical Affairs and how they support organizational goals in pharmaceutical and medical device companies.

Highlight Strategic Value: Demonstrate the strategic importance of Medical Affairs in driving innovation, ensuring compliance, and aligning with healthcare provider and patient needs.

Promote Best Practices: Share insights and practical strategies to optimize the impact of Medical Affairs teams in a dynamic and competitive healthcare environment.

The event doors open at 4:30 PM, please arrive on-time to check in and pick up your name badge (you will need your badge to enter the event).

Location:

Pinstripes

3300 Kirby Drive,

Houston, TX 77098

Agenda:

4:30 PM: Doors Open/Networking and Cocktails

5:00 – 6:00: Panel Discussion

6:00 – 7:00: Networking Cocktail Reception

This event is free for all MAPS members and $50 USD for non-members.

Register

Host and Panelist:

Robin Winter-Sperry

MAPS Americas Region President

Host and Panelist:

Denise Clark

Regional Medical Director

Amgen

Host and Panelist:

Tonya West

National MSL Director

AbbVie

Maximizing the Value of Medical Insights
2025-04-15 10:00 - 11:00 (America/New_York)
Objectives:

– Define types of medical insight metrics that are of value to the organization

– Create a communication plan for the right people at the right time, demonstrating the value of medical insights

– Identify some ways to make your medical insights process sustainable

Register

Speakers:

Jessica Hargrove

Brant Jarret

Lori Klein

Melissa Santiago

MAPS 2025 Japan Medical Affairs Summit
2025-04-16 00:00 - 2025-04-17 23:59 (Asia/Tokyo)
Save the date!!

Launch Excellence MasterClass: London
2025-05-12 00:00 - 2025-05-13 23:59 (Europe/London)
Add to Calendar

Save the date! Join us in London on May 12-13, 2025. More Information Coming Soon.

Leadership MasterClass: London
2025-05-12 00:00 - 2025-05-13 23:59 (Europe/London)

MAPS 2025 EMEA Meeting: London
2025-05-12 00:00 - 2025-05-14 23:59 (Europe/London)
Add to Calendar

Save the date!! Join us in London on May 12-14, 2025. More Information Coming Soon.

Harnessing Data Analytics to Advance Medical Affairs Excellence
2025-05-16 10:00 - 11:00 (America/New_York)
In today’s rapidly evolving healthcare landscape, claims data analytics serves as a vital, transformative tool for Medical Affairs professionals. By unlocking insights from real-world patient journeys and healthcare utilization, claims data enables Medical Affairs teams to make data-driven decisions that enhance strategic initiatives, inform evidence generation, and drive value-based outcomes.

The integration of artificial intelligence (AI) further amplifies these capabilities, allowing for more sophisticated data analysis, predictive modeling, and identification of emerging trends. This webinar will explore how claims data analytics can be effectively integrated into Medical Affairs workflows to address key challenges and opportunities in the field.

Attendees will gain insights into use cases such as optimizing stakeholder engagement, identifying unmet clinical needs, closing care gaps, supporting evidence-based messaging, and measuring real-world impact. Through case study examples and interactive discussions, this webinar aims to equip participants with practical knowledge and tools to leverage claims data for advancing industry standards and shaping the future of Medical Affairs.

Learning Objectives:

– Identify strategies for incorporating real-world evidence to inform Medical Affairs initiatives.

– Understand the role of claims data analytics in Medical Affairs decision-making.

– Learn how AI enhances predictive modeling and trend identification in healthcare analytics.

– Explore case studies showcasing the impact of claims data in optimizing stakeholder engagement and improving patient outcomes.

Register

Moderator & Speakers:

Lori Klein, PharmD

Partner, Medical & Scientific Affairs Practice Lead

Putnam

Speaker:

Nikheel Kolatkar, MD, MPH

VP, US Medical

Genentech

Speaker:

Sonal Bhatia

Former Chief Medical Officer

Speakers:

Jo Ann Saitta

Partner, Global Data Strategy, Analytics and AI Practice Lead

Putnam

Mastering Cross-Functional Collaboration for Launch Success
2025-05-21 10:00 - 11:00 (America/New_York)
Life science companies, particularly pharma are notoriously siloed organizations. However, the importance of diverse input and exchange across functions, strategic alignment and holistic implementation of key activities, such as stakeholder engagement, highlight the need for effective cross-functional collaboration. While its scientific expertise, healthcare system knowledge and leadership of critical pre-launch make Medical Affairs a central player in the brand team, it is the ability to collaborate that is most highly valued. In a recent survey of nine general managers and nine business unit directors, cross-functional collaboration was rated the most highly valued competency for Medical Affairs. Along with the next most highly rated value drivers of scientific acumen, engagement excellence, understanding the current issues impacting HCPs and the patient journey, these results strengthen the perception of Medical Affairs as therapeutic experts and organizational leaders. So what does effective collaboration look like for Medical Affairs? And what are best practices? This webinar will provide attendees with perspectives on these important questions from industry leaders across functions, including Commercial, Marketing, Market Access and R&D, and practical advice on how to master the art of collaboration to improve cohesion for collective success.

Learning Objectives:

Objective 1: Recognize the importance of effective collaboration by Medical Affairs in launch preparation

Objective 2: Understand what other functions value in their collaboration with Medical Affairs

Objective 3: Know the secrets to effective collaboration to maximize organizational value for launch success

Register

Moderator:

David Kelaher

Senior Director, Medical Affairs

IQVIA

Speaker:

Shannon Faught

Chief Commercial Officer

Alora Pharmaceuticals

Speaker:

Chris Boulton

Vice President, Global Marketing Therapy Area Head – Obesity

Amgen

Speaker:

Katie Pascoe

Global Compound Market Access Lead at Janssen – Oncology

Johnson & Johnson

Speaker:

Rupert Vessey

Chief Scientist

Flagship Pioneering

Speaker:

Josie Downey

General Manager and Managing Director, Australia and New Zealand

Merck Healthcare

Leveraging New MAPS Standards & Guidance to Drive Strategic Medical Planning and Demonstrate Value
2025-06-18 10:00 - 11:00 (America/New_York)
This webinar will explore the recently released MAPS Standards & Guidance (S+G) documents, “Measuring Value and Impact in Medical Affairs” and “Strategic Medical Planning Guide.” These resources empower Medical Affairs professionals to implement impactful strategies that align with organizational goals and stakeholder priorities.

Join thought leaders from the Medical Strategy & Launch Excellence FAWG to gain insights into:

– Frameworks for effective medical strategy development and tactical execution.

– Strategies to evaluate meaningful value and impact using goal-based and outcome measures.

– Practical tools for cross-functional collaboration and operational excellence.

– Through interactive discussions and expert perspectives, attendees will learn how these S+G documents provide actionable guidance to support innovation, enhance decision-making, and foster measurable impact in Medical Affairs.

– This session is ideal for Medical Affairs professionals seeking to elevate their strategic planning efforts and demonstrate value across the healthcare ecosystem.

Learning Objectives:

– Learn how to apply goal-based outcome measures to enhance and communicate the impact of Medical Affairs within your organization

– Gain a thorough understanding of core frameworks of the MAPS Strategic Medical Planning and Value & Impact Standards & Guidance documents.

– Master the application of foundational elements in medical affairs strategic planning, from strategy development to tactical execution

Register

Moderator:

Arron Mungul

Founder

Apogee Life Sciences

Speaker:

Leah Williams

Director, commercial Development, Hematology TA

CSL Behring

Speaker:

Emily Howman

Healthcare strategy and communications consultant

Speaker:

Amanda Henkel

Practice Area Lead, Rare Disease at MEDiSTRAVA

Inizio

Speaker:

Yi Arnold

Team Lead, Medical Affairs, Connector, Marathoner, Coach, Ultimate Optimist

Integra Life Sciences

The Future is Agentic: Unlocking AI’s Potential for Medical Insights
2025-06-19 10:00 - 11:00 (America/New_York)
Artificial intelligence is redefining how Medical Affairs teams gather, interpret, and act on medical insights—moving from retrospective reviews to real-time, strategic intelligence. This webinar will explore the emerging role of agentic agents, a new class of AI tools capable of autonomous task execution, contextual reasoning, and dynamic insight generation. Attendees will gain a clear understanding of current and near-future applications of AI in insights analysis, along with actionable guidance for preparing their teams to harness its full potential responsibly and effectively.

Register

Speakers:

Lori Klein

Brant Jarrett

Tony Page

Randi Kline

Carole Catapano

Prem Sundivakkam

Enhancing Collaboration: Streamlining Access to Scientific Literature for Medical Affairs Teams
2025-06-24 10:30 - 11:30 (America/New_York)
Join a conversation with three medical affairs industry experts about the increasing importance of timely access to high-quality scientific content. This moderated panel discussion will focus on best practices for medical affairs teams when acquiring, managing, and disseminating scientific articles and other content to internal stakeholders, as well as sharing content externally in ways that are copyright compliant.

Participants will explore strategies for ensuring timely access to high-quality, relevant scientific literature that’s procured and distributed in ways that promote copyright. Participants will also discuss utilizing digital tools to facilitate literature surveillance, streamline content distribution, and foster effective communication between teams. Emphasis will be placed on how to support decision-making and enhance cross-functional collaboration, particularly from the perspective of medical information and medical excellence.

Attendees will gain insights into overcoming challenges related to content curation and the alignment of scientific information with organizational needs. After participating in this session, attendees should be able to:

Identify strategies to reduce copyright risk when procuring and sharing content

Understand best practices for searching for and acquiring literature, as well as sharing content externally in a copyright compliant manner

Possess insight into how other medical affairs teams organize and manage their documents and citations

State common challenges when sharing scientific content with stakeholders and gain insight into how other organizations overcome these challenges today

Learning Objectives

After participating in this session, attendees should be able to:

Identify strategies to reduce copyright risk when procuring and sharing content.

Understand best practices for searching for and acquiring literature.

Gain insight into how other medical affairs teams organize and manage their documents and citations.

Recognize common challenges when sharing scientific content with stakeholders and understand how other organizations overcome these challenges.

Register

Moderator:

Jackie Fucile

Product Solutions Manager

CCC

Speaker:

Cassie Singleton

Director, Medical Information

Becton Dickinson (BD)

Speaker:

Sarah Guadagno, Ph.D

Founder/Principal

8X Life Science Communications

MAPS Northeast Chapter Event - Career Progression and Development Discussion
2025-06-24 15:30 - 18:00 (America/New_York)
Join MAPS Chapter Leads and experienced Medical Affairs professionals for a discussion on career paths and development opportunities in Medical Affairs and the MSL field. Explore available resources and support for career growth.

The panelist will outline the skills companies need for current and future Medical Affairs challenges. Participants will learn about available resources through MAPS, other networks, and how they can leverage their own network.

FREE for MAPS Members

$50 USD for Non-Members (Non-members may apply the registration fee to their first year of individual membership if an application is submitted with 30 days after the event).

Register

Thank you to our Sponsor:

Venue:

Cactus Life Sciences – Stockton Conference Room-1st Floor

214 Carnegie Center, Suite 102

Princeton, New Jersey 08540

Agenda:

3:30 PM: Doors Open

4:00 – 5:00: Panel Discussion and Q&A –

Discussion Moderator:

Renu Juneja, PhD, MAPS Northeast/Mid-Atlantic Chapter Lead

Panelist:

Fatima Ahmad, PharmD

Hahn-Ey Lee, MD, PhD, MBA

Devi Mukhrjee, PhD

Elvira D’souza, Cactus

5:00– 6:00: Closing Remarks & Networking (Refreshments and lite snacks provided)

Moderator:

Renu Juneja, PhD

President, ADPAL, LLC

MAPS Northeast/Mid-Atlantic Chapter Lead

Panelist:

Fatima Ahmad, PharmD

US Medical Affairs Team Lead for Rare Endocrine and Rare Renal Disorders

Novo Nordisk

Panelist:

Hahn-Ey Lee, MD, PhD, MBA

International Medical Lead – Vaccines and Antivirals & Anti-infectives

Pfizer

Panelist:

Elvira Dsouza

President

Cactus Communications

Medical Affairs' Data Dilemma and The Path To Influence
2025-07-18 10:00 - 11:00 (America/New_York)
In a field where the essence of your work is rooted in scientific discourse rather than direct sales, showcasing your team’s value to your organization and stakeholders is a nuanced challenge. How do you establish Medical Affairs as a strategic pillar? It requires more than routine reports; it demands a comprehensive understanding of stakeholder needs and a clear articulation of long-term impact—a task easier said than done.

Learning Objectives

Data Prioritization and Storytelling: Learn to distill and prioritize data to craft compelling narratives that highlight the true impact of Medical Affairs. Discover the power of asking critical “whys” to uncover the significance of your data.

Creating Meaningful Benchmarks: Understand how to establish appropriate benchmarks in a field where conventional measures don’t always exist, guiding you to effectively demonstrate your contributions.

Demonstrating Patient Impact: Develop strategies to showcase your value and influence on patient outcomes through scientific exchange and research, innovating beyond traditional benchmarks and metrics.

Fostering Collaborative Partnerships: Explore the importance of collaboration in advancing unbranded disease education and new research initiatives, inspired by successful models that are driving innovation within the industry.

Register

Speakers:

Moderator

Ujwal Pyati

Chief Medical Officer

Real Chemistry

Speaker:

Briana Belford

Practice Leader, Integrated Intelligence

Real Chemistry

Speaker:

Ann Wheeler

VP, North America Medical Affairs

Indivior

The Future of Research Visibility: Beyond Traditional Metrics
2025-07-25 10:00 - 11:00 (America/New_York)
Unlock the full potential of your scientific content strategy by exploring how Medical Affairs teams are beginning to think beyond traditional citations and toward more meaningful ways to measure the impact of their scientific content.

In this session, a panel of experts will share their current experiences, challenges, and perspectives on tracking and interpreting the broader impact of scientific content.

While panelists may monitor content using different metrics, the discussion will explore what’s potentially useful and where the real opportunities lie. The conversation will begin by examining how scientific communications are evolving in a fast-moving, multi-channel environment. It will then consider how to track supplementary content and what the benefits of this might be.

The panel will also reflect on the kinds of metrics that could offer value beyond citations, such as indicators of engagement, visibility, and influence. These ideas will be grounded in practical relevance for Medical Affairs strategy, helping attendees think about how insights might be applied in real-world planning.

The session will close with a look ahead to what the future may hold for metrics innovation and impact measurement.

Learning Objectives:

– Consider how emerging metrics and tools might support Medical Affairs strategy and planning in the future.

– Gain insight into how different organizations are approaching impact measurement, recognizing a range of experiences and stages in adoption.

– Identify opportunities and challenges in tracking metrics beyond traditional citations, including indicators of engagement, attention, and influence.

– Explore the potential role of tracking publication extenders and their engagement across different channels.

Register

Speakers:

Moderator:

Natalie Jonk

Marketing segment Lead

Digital Science

Speaker:

Shehla Sheikh

Head of Medical communication & Publications

Kyowa Kirin

Speaker:

Kim Della Penna

Scientific Communications Director, Lymphoma/Myeloid/Multiple Myeloma

Johnson & Johnson

Speaker:

Myriam Cherif

Founder, Formerly Regional Medical Director

GSK

Speaker:

Carlos Areia

Senior Data Scientist

Digital Science

Natural History Studies: Selecting the Right Delivery Method
2025-08-22 10:00 - 11:00 (America/New_York)
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.

Join this session to:

Review the range of delivery options

Take a deep dive into innovative approaches to consider: AI-assisted chart review, and industry/advocacy partnerships

Learning Objectives

Understand the importance of natural history studies in rare diseases and personalized medicine.

Explore various delivery methods for conducting natural history studies.

Evaluate innovative approaches, including AI-assisted chart review and industry/advocacy partnerships.

Identify key considerations for selecting the most effective delivery method based on study goals and patient population.

Register

Speakers:

Moderator

Barbara Arone

Vice President, Medical Affairs, Real World Solutions

IQVIA

Speaker:

Angela Kennedy

Senior Director, Provider and Patient Association

IQVIA

Speaker:

Stuart Turner

TA Head, General Medicines

Global RWE & Outcomes

A Rapidly Changing Regulatory Landscape: What Medical Affairs Leaders Should Know
2025-09-12 10:00 - 11:00 (America/New_York)
Recent shifts in U.S. health policy—from revised vaccine recommendations and NIH budget cuts to proposed bans on direct-to-consumer pharma advertising—are redefining the regulatory environment in which Medical Affairs operates. As the pace of change accelerates, Medical Affairs professionals must be proactive in understanding how emerging legislation, transparency expectations, and cost-containment strategies may impact their work.

This session brings together seasoned experts and leaders in Medical and Regulatory Affairs to explore the implications of a rapidly evolving policy landscape. Topics will include real-world examples of recent or proposed changes and practical steps Medical Affairs leaders can take to ensure compliance, maintain public trust, and remain agile in an uncertain environment.

Learning Objectives

Recognize how recent and proposed healthcare policy changes may impact Medical Affairs operations, strategy, and compliance expectations.

Understand the increasing emphasis on transparency, conflict-of-interest management, and ethical decision-making in a changing regulatory climate.

Identify proactive steps Medical Affairs leaders can take to align cross-functional teams and ensure preparedness in the face of regulatory shifts.

Explore how automation, digital tools, and audit-ready systems can support compliance, adaptability, and strategic decision-making.

Register

Speakers:

Moderator:

Alex Reinthal

Vice President of Product,

BP Logix

Speaker:

Michelle Chernock

Founder

Leaders in Medical Affairs

Speaker:

Jethro Ekuta

Chief Regulatory & Safety Officer

Ascendis

Speaker:

Robert Kaper

Former VP of Global Medical Affairs

Otsuka

Operationalizing Medical Strategy: A Success Story in Demonstrating Value and Impact
2025-09-19 10:00 - 11:00 (America/New_York)
Medical Affairs organizations are increasingly challenged to demonstrate their value through aligned, strategic execution that drives meaningful clinical impact. This webinar highlights how one organization successfully applied the MedImpact Model™ to achieve clarity of purpose, functional alignment, and measurable behavior change in the field.

The session will walk attendees through how the three pillars of the MedImpact Model™ —Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action. Whether you use the MedImpact Model™ or your organization’s own framework, participants will gain practical insights in using a proven framework to empower cross-functional teams and field medical professionals to elevate their role in enabling informed therapeutic decisions and advancing patient care.

Learning Objectives

Understand how a proven framework like the MedImpact Model™ (Impact Story, Contributions, and Execution) was successfully used by an organization to drive aligned strategy and clinical behavior change.

Recognize how tactical execution can be elevated through structured planning, team alignment, and targeted coaching within a Medical Affairs organization.

Apply key lessons and practical insights to operationalizing a medical impact framework within their own teams and organizations.

Register

Speakers:

Moderator:

Linda Traylor

PhD, VP, Head of Global Medical Excellence

Acceleration

Speaker:

Joseph Giuliano

Managing Director,

Rare Medical Affairs

Speaker:

Matt Nelson

Head of US Medical Affairs,

Amicus Therapeutics

MAPA-MAPS Australasia Medical Affairs Summit 2025: Sydney
2025-09-24 00:00 - 2025-09-25 23:59 (Australia/Sydney)
Save the date!! Join us in Sydney September 24-25, 2025.

AI and the HCP Experience: Implications for Medical Affairs
2025-10-10 10:00 - 11:00 (America/New_York)
Artificial Intelligence is already reshaping how healthcare is delivered and how Medical Affairs operates. In this interactive webinar, the panel will share data from healthcare decision makers about the use of AI in health systems and discuss the impact on how Medical Affairs engages with healthcare providers and executes educational programming.

Participants will gain a deeper understanding of how AI is influencing medical decision-making and care coordination and how this will impact medical education and evidence generation. Attendees will leave equipped with actionable strategies to adapt, lead, and innovate in an AI-driven healthcare ecosystem.

Learning Objectives

Recognize how AI is currently being used by health systems and healthcare professionals in clinical practice.

Evaluate the implications of AI adoption on Medical Affairs functions, such as scientific communications, evidence generation, and stakeholder engagement.

Identify key challenges and opportunities in integrating AI into Medical Affairs workflows, including data quality, insight generation, and cross-functional collaboration.

Register

Speakers:

Moderator:

Jason McDonough

PhD, CMPP, SVP, Medical Strategy

Precision AQ

Speaker:

Sam Vaudrey

Sr. Director, Innovation & Technology

Precision AQ

Speaker:

Greg Gregory

PhD, EVP, Partner

Precision AQ

Speaker:

Adam Rodman, MD, MPH, FACP

Hospitalist, Beth Israel Deaconess Medical Center

Assistant Professor, Harvard Medical School

Director of AI Programs, Shapiro Center for Research and Education, BIDMC

Co-director, iMED Initiative at BIDMC

Thriving in Times of Transformation: Effective Leadership Practices for Supporting Teams in the Rapidly Evolving Landscape of Medical Affairs: Part 1 of 3: Five Elements of Emotional Intelligence
2025-10-22 10:00 - 11:00 (America/New_York)
In today’s rapidly evolving Medical Affairs landscape, technical expertise alone is no longer enough. To truly thrive in times of transformation, leaders must cultivate emotional intelligence—the foundation of effective leadership.

Join us for Part 1 of our 3-part, interactive 60-minute webinar series designed specifically for members of the Medical Affairs Professional Society (MAPS) who are eager to elevate their leadership and management capabilities. This session will explore the five elements of emotional intelligence—self-awareness, self-regulation, motivation, empathy, and social skills—and how they can be harnessed to build resilient, high-performing Medical Affairs teams.

Through real-world case studies, peer insights, and guided reflection, you’ll learn how emotionally intelligent leadership can:

Strengthen team cohesion and trust

Improve communication and collaboration

Enhance decision-making under pressure

Foster a culture of empathy and accountability

Register

Speakers:

Co-Moderator

Matthew John Rice

Learning Architect Director, Center for Scientific Exchange Excellence

Merck & Co., Inc.

Co-Moderator:

Deborah Braccia, PhD, MPA

Founder & Principal,

DVB Consulting

Medical Affairs Technology and Innovation Symposium 2025
2025-10-23 12:00 - 18:00 (America/New_York)
Join us for this highly interactive session featuring two expert-led panel discussions and a collaborative small-group workshop. Hear firsthand how Medical Affairs leaders are harnessing AI to transform insights, evidence, and communication—and what capabilities, structures, and strategies made those efforts successful. Then, dive into a facilitated workshop to identify how your team can begin or advance your AI journey.

In this event attendees:

• Collaborate with peers and panelists to draft your own roadmap for implementing AI, including identifying value opportunities, capability gaps, and approaches for measuring success.

• Learn how Medical Affairs teams launched successful AI initiatives in insights, evidence generation, and scientific communication and what business drivers and lessons shaped the outcomes.

• Understand the cross-functional, technical, and organizational capabilities needed to scale and sustain AI solutions in Medical Affairs.

Location:

Convene One Boston Place201 Washington StBoston, Massachusetts 02108United States

Event supported by:

Registries 101: A Medical Affairs' Value Primer
2025-10-29 10:00 - 11:00 (America/New_York)
Registries are often mentioned but much less frequently implemented. As such, many Medical Affairs professionals have not had the opportunity to put “hand on” from either a conceptual or technical standpoint. In this 60-minute webinar, a cross-functional group of experts will present the basics of why, when and how to make the most of a registry as we look to assess and address care gaps. A range of perspectives from RWE expert to HQ medical director to field medical director will be presented and examples of patient, product and disease state registries will be considered.

Objectives:

1. Describe the value of registry data in evidence generation

2. Gain insight into the purpose, design and operationalization of registries

3. Articulate the role of Medical Affairs in the design and conduct of registries

4. Appreciate the challenges and opportunities when analyzing registry data

Register

Speakers:

Moderator

Diana Morgenstern

MD, FACP, Head, RWE and Outcomes Research

Viatris

Speaker:

Angela Williams

VP, Global Head HEOR

Kyowa Kirin

Speaker:

PhD, Vice President, Medical Affairs Strategy

ImmunityBio

Updates to Insights Standards and Guidance: Evolving Best Practices
2025-10-30 10:00 - 11:00 (America/New_York)
Join us to review what’s new over the past few years. Topics will include the increasing importance of commercial collaboration, strategic frameworks, incorporation of AI, multi-modal data and impact metrics. Bring your questions!

Register

Speakers:

Jo Ann Antenor – Sobi

Brant Jarrett – Mallinckrodt Pharmaceuticals

Tony Page – Within3

Pete Piliero – MAPS

Prem Sundivakkam – Pfizer

Medical Affairs In Early Stage Development? Seriously?
2025-10-31 10:00 - 11:00 (America/New_York)
According to the OECD, the aging population is projected to increase global healthcare spending by many trillions of dollars in the coming decades.

Once the notorious killer, cardiovascular-related mortality has decreased over time—leading to an increase in prevalence of other diseases.

Brain disorders are expected to triple in cost to $15 trillion by 2030, and cancer cases are projected to increase by 77% by 2050 (McKinsey, WHO).

Healthcare systems aim to drive costs down while increasing both lifespan and health span.

It still costs over $2 billion to develop a new therapeutic (Deloitte).

60% of launched drugs don’t hit sales forecasts, and of those that miss first-year targets, only 20% recover (ZS, Trinity, IQVIA).

The upcoming patent cliff may wipe $180 billion off revenue in 2027/2028 (FT/Evaluate).

Increasingly stringent market conditions have become the norm, with policies such as Most Favored Nation pricing, drug tariffs, and EU joint HTA.

Pharmaceutical product development is more challenging than every before. Yet, most organisations do not have Medical Affairs presence in early-stage development. Why would you? Most organisations involve Medical Affairs at Phase 3 before pivotal trial read-out. This is already late if we consider the challenges affecting drug development and chances of launch success. Involving Medical Affairs early already may increase chances of progressing programmes to filing as well as increasing chances of a successful launch and return on investment.

Join our experts who will be covering the burning platform that is early stage drug development, listen and ask them questions on their thoughts on the role of Medical Affairs in early-stage drug development.

Learning Objectives

Understand the benefits and opportunities of involving Medical Affairs in early therapeutic development stages.

Learn how a robust Medical Affairs function can shape development strategy and support launch readiness.

Define the ideal role Medical Affairs should play in early product development.

Register

Speakers:

Moderator

Rakesh Kantaria

Founder and CEO

Circuit Medical

Speaker:

Dr. Samin Saeed

VP, Early Medical Pipeline, Specialty Care

GSK

Speaker:

Jan Schadrack

VP, TA Head Neuroscience and Rare Disease; Product Development Medical

Roche

Speaker:

Paulo Fontoura

Chief Medical Officer

Xaira

Redefining Evidence Generation: Innovative AI-Enabled Approaches for a New Era of Therapies
2025-11-07 10:00 - 11:00 (America/New_York)
Medical Affairs is at the center of a shifting evidence landscape. As newly approved therapies and evolving standards of care bring urgent questions about safety, effectiveness, and utilization, traditional registries and clinical trials too often fall short—delivering answers that are delayed, incomplete, or unrepresentative.

This webinar will explore how new approaches are transforming evidence generation for registries and studies by leveraging structured and unstructured electronic health records, creating flexible, living platforms that adapt as new standards of care and questions emerge. While we will highlight an Alzheimer’s initiative as an example of innovation in a complex and evolving disease area, the approaches and lessons discussed are broadly applicable across therapeutic areas.

Attendees will gain perspective on how these methods can support Medical Affairs in building stronger evidence strategies, driving scientific exchange, and enabling better communication with payers, providers, and regulators.

Learning Objectives

Recognize why traditional observational methods often fail to meet evolving evidence needs.

Understand how AI and automation can transform real-world evidence generation by improving efficiency, inclusivity, and adaptability.

Learn from an Alzheimer’s initiative as an example of how innovative approaches can build scalable, living evidence platforms.

Identify how Medical Affairs can leverage these approaches to strengthen communication, support access, and drive evidence strategies across therapeutic areas.

Register

Speakers:

Moderator

Tiffany Hadzi

VP Client Services,

OM1

Speaker:

Carl Marci, MD

Chief Clinical Officer

OM1

Speaker:

Ann Hartry

Associate Vice President, Value, Evidence, & Outcomes, Neuroscience,

Lilly

Medical Affairs Career Progression and Development Discussion - Hosted by the MAPS - Houston Chapter
2025-11-13 18:00 - 19:00 (America/North_Dakota/Center)
Program Goals:

Highlight the skills and expertise needed to meet current and future business needs and strengthen capabilities in the Medical Affairs area. As well as enhancing the participants awareness of various pearls, tools, and resources available to them and how to obtain

Program Objectives:

Discuss career pathways and development opportunities to foster a culture of continuous learning and growth within the Medical Affairs sector and MSL field. Provide resources and support for career exploration, including:

Informational interviews

Career counseling

Networking opportunities

Informational Interviews

Unlocking Externally Sponsored Research Value
2025-11-21 10:00 - 11:00 (America/New_York)
As Biopharma and regulators’ appetite for understanding the value of medicines in the real world increases—alongside the desire to be closer to patients and providers—a new lens is being placed on Externally Sponsored Research (ESR) as a key pillar in Evidence Generation (EvGen). The ability to execute EvGen strategies through Company Sponsored Studies (CSS) alone is being stretched, resulting in many companies looking to more strategic use of ESR, including with registrational intent and for signal seeking (e.g., biomarker exploration).

Learning Objectives

Articulate the key trends affecting ESR today.

Understand how industry leaders are using ESR to support evidence generation.

Identify best-practice techniques for delivery of ESR trials.

Register

Speakers:

Moderator:

Kelli Rock-Walker

Managing Director, Medical Affairs

Syneos Health

Speaker:

Kelly Haines

Senior Director, Head, Medical Study Operations

Regeneron

Leading Medical Affairs Through Transformation: Applying Goleman’s Six Styles with Emotional Intelligence
2025-12-03 10:00 - 11:00 (America/New_York)
Ready to lead change with confidence? Part 2 of our 3-part MAPS series turns insight into action. In Part 1, we unpacked Daniel Goleman’s five elements of Emotional Intelligence (EI). Now we put EI to work.

Unlock the leadership edge top Medical Affairs teams rely on. In this fast-paced, interactive 60-minute session, you’ll see how Goleman’s six leadership styles—powered by EI—deliver real-world results: faster alignment, stronger collaboration, and measurable performance. Through practical case studies, peer exchange, and guided reflection, you’ll learn exactly when to flex authoritative vs. democratic, when affiliative trumps pacesetting, and how coaching elevates talent during transformation. Walk away with a clear playbook to lead confidently, influence cross-functional partners, and build a high-trust, high-impact culture—starting immediately.

Register

Speakers:

Co- Moderator:

Matthew John Rice

Learning Architect Director, Center for Scientific Exchange Excellence

Merck & Co., Inc.

Co-Moderator:

Deborah Braccia, PhD, MPA
